KCNN4 and prostate cancer: In addition, KCa3.1 is overexpressed in a variety of human tumor cell lines and human biopsy samples including glioblastoma [30–32], pancreatic cancer [12], prostate cancer [33], endometrial cancer [16] and breast cancer [15, 34].